ArticleThe Journal of biological chemistry2026
Low-dose EGFR inhibition unlocks ferroptosis susceptibility to sensitize chemotherapy in EGFR-high triple-negative breast cancer.
Xiaoxi Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.